Based on the median value of the relative HHLA2 mRNA copies, 111 patients with gastric cancer were divided into a high-expression group (n = 55) and a low-expression group (n = 56) to investigate the relationship between expression of HHLA2 and clinicopathological factors. Here, HHLA2 is linked to gastric cancer.